top of page
COVID-19 & Sports
COVID-19 & Sports
COVID-19 & Sports
Career
Contact Us
Vancouver Infectious Diseases Centre
About Us
About Dr. Conway
About Dr. Truong
Services
Clinical Services
HCV / HIV Patient Care
Research Involvement
Community Outreach
VUHC
Published Work
Press
Radio
Webinars
Hantavirus
HCV & HIV Care
COVID & Sports
COVID-19: 2022 - Present
COVID-19
DONATE
More
Use tab to navigate through the menu items.
Published Work
From observational studies to clinical trials, the VIDC research team shares our findings with the medical community at international conferences.
​
Visit us at an upcoming conference >
All Posts
Conference Poster
Research Paper
Blog
Search
COVID-19 in homeless populations: unique challenges and opportunities.
Vulnerable populations, such as those in urban Vancouver, are both more susceptible to COVID-19 and less able to implement recommended...
Jun 25, 2020
Glecaprevir/pibrentasvir+sofosbuvir: An optimal retreatment strategy in the setting of HCV NS5A ...
Some individuals do not achieve a cure of their hepatitis C virus (HCV) infection due to non-adherence or resistance associated substitution
Feb 11, 2020
Sofosbuvir and velpatasvir in the treatment of chronic hepatitis C
Advances in hepatitis C virus (HCV) treatment led to the development of highly effective all oral direct acting antiviral regimens.
Dec 16, 2019
Low rate of reinfection among a cohort of people who use drugs successfully treated for hepatitis C
Concerns about reinfection may be limiting HCV treatment uptake among people who use drugs (PWUD), with rates of 17.1/100 person-years in...
Oct 14, 2019
Diagnosis and treatment of hepatitis C virus infection: a tool for engagement with people who inject
Vancouver’s Downtown Eastside (DTES) faces the interrelated challenges of poverty, homelessness, mental health, addiction, and medical issue
Jul 17, 2018
bottom of page
